Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of refractory Hodgkin's disease with high-dose cytosine arabinoside and mitoxantrone in combination. Results of a clinical phase II study of the German Hodgkin Study Group.
Hiddemann W, Schmitz N, Pfreundschuh M, Pflüger KH, Ollech-Chwoyka J, Tirier C, Maschmeyer G, Kirchner H, Wagner T, Koch P, et al. Hiddemann W, et al. Among authors: koch p. Cancer. 1990 Sep 1;66(5):838-43. doi: 10.1002/1097-0142(19900901)66:5<838::aid-cncr2820660504>3.0.co;2-r. Cancer. 1990. PMID: 2386912
Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study Group.
Tesch H, Diehl V, Lathan B, Hasenclever D, Sieber M, Rüffer U, Engert A, Franklin J, Pfreundschuh M, Schalk KP, Schwieder G, Wulf G, Dölken G, Worst P, Koch P, Schmitz N, Bruntsch U, Tirier C, Müller U, Loeffler M. Tesch H, et al. Among authors: koch p. Blood. 1998 Dec 15;92(12):4560-7. Blood. 1998. PMID: 9845521 Free article. Clinical Trial.
Results of a randomized double-blind placebo-controlled trial evaluating sequential high-dose cytosine arabinoside/mitoxantrone chemotherapy with or without granulocyte/macrophage-colony-stimulating factor in high-risk myelodysplastic syndromes.
Verbeek W, Wörmann B, Koch P, Aul C, Hinrichs HF, Balleisen L, Rowe JM, Bennett J, Haase D, Fonatsch C, Heinecke A, Büchner T, Hiddemann W. Verbeek W, et al. Among authors: koch p. J Cancer Res Clin Oncol. 1999;125(6):369-74. doi: 10.1007/s004320050288. J Cancer Res Clin Oncol. 1999. PMID: 10363570 Clinical Trial.
Dose escalation of cytotoxic drugs using haematopoietic growth factors: a randomized trial to determine the magnitude of increase provided by GM-CSF.
Pfreundschuh M, Hasenclever D, Loeffler M, Ehninger G, Schmitz N, Kirchner H, Koch P, Lathan B, Rueffer U, Sextro M, Franklin J, Tesch H, Diehl V; German Hodgkin's Lymphoma Study Group. Pfreundschuh M, et al. Among authors: koch p. Ann Oncol. 2001 Apr;12(4):471-7. doi: 10.1023/a:1011108722666. Ann Oncol. 2001. PMID: 11398878 Free article. Clinical Trial.
1,161 results